Literature DB >> 16543965

Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder.

Verena Schroeder1, Esther Meili, Trinh Cung, Peter Schmutz, Hans P Kohler.   

Abstract

In 1960, the first case report on factor XIII deficiency was published describing a seven-year-old Swiss boy with a so far unknown bleeding disorder. Today, more than 60 mutations in the factor XIIIA- and B-subunit genes are known leading to congenital factor XIII deficiency. In the present study, we describe six novel mutations in the factor XIII A-subunit gene. Additionally, we present the molecular characterisation of the first described patient with congenital factor XIII deficiency. The six novel mutations include a small deletion, Glu202 delG, leading to a premature stop codon and truncation of the protein, and a splice site mutation at the exon 10/intron 10 boundary, +1G/A, giving rise to an incorrect spliced mRNA lacking exons 10 and 11. The remaining four mutations are characterised by the single amino acid changes Met159Arg, Gly215Arg, Trp375Cys, and His716Arg, and were expressed in COS-1 cells. Antigen levels and activity of the mutants were significantly reduced compared to the wild-type. The patient described in 1960 also shows a single amino acid change, Arg77Cys. Structural analysis of all mutant enzymes suggests several mechanisms leading to destabilisation of the protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543965

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII.

Authors:  Shoko Maeda; Wei Guang Zhang; Masayoshi Souri; Vivien C Yee; Akitada Ichinose
Journal:  J Biochem       Date:  2012-08-25       Impact factor: 3.387

Review 2.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 3.  How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.

Authors:  Hojat Shahraki; Akbar Dorgalaleh; Majid Fathi; Shadi Tabibian; Shahram Teimourian; Hasan Mollanoori; Alireza Khiabani; Farhad Zaker
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

Review 4.  [Hereditary coagulation factor XIII deficiency: three cases report and literaure review].

Authors:  P P Xu; B J Ding; M J Li; J P Liu; L Liu; A Xia; W Q Liu; K S Zhou; H F Zhao; H Zhou; Y P Song
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-03-14

Review 5.  Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?

Authors:  Wolfgang Korte
Journal:  J Blood Med       Date:  2014-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.